Top Markets
#1 Derive Derive +28.10%
#2 MowCat MowCat +25.96%
#3 Geodnet Geodnet +22.61%
#4 Cross Cross +15.32%
#5 Humanity Humanity +12.43%
#6 aPriori aPriori +10.37%
#7 Biconomy Biconomy +9.73%
#8 The Bitcoin Bull The Bitcoin Bull +8.51%
#9 Cap Cap +8.46%
#10 Velvet Velvet +8.39%
Coin of the day
Derive Derive
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Pasithea Therapeutics Corp. Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp.

KTTA
Kedudukan dalam Saham #35798
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the... Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Harga Saham
$0.46
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$3.42M
Perubahan (1 hari)
3.60%
Perubahan (1 tahun)
-34.54%
Negara
US
Perdagangan Pasithea Therapeutics Corp. (KTTA)

Kategori

Healthcare
Nisbah P/B bagi Pasithea Therapeutics Corp. (KTTA)
Nisbah P/B pada 2026 TTM: 0
Menurut laporan kewangan dan harga saham terkini Pasithea Therapeutics Corp., nisbah P/B semasa (TTM) ialah 0. Pada akhir 2026, nisbah P/B syarikat ialah 0.
Sejarah nisbah P/B untuk Pasithea Therapeutics Corp. dari 2026 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
Tidak cukup data untuk tarikh yang disediakan.
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE